DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20210236

Risk factors associated with peripheral neuropathy among diabetic individuals: a case control study

Christa Kingston, Aravindan J., Srikumar Walsalam

Abstract


Background: Diabetic neuropathy is one among the most common complication in diabetes mellitus. Diabetic peripheral neuropathy hinders the quality of life causing morbidity and mortality. The purpose of this study was to find the risk factors associated with diabetic neuropathy.

Methods: This case control study involved 100 diabetic patients attending the Dohnavur fellowship hospital, Dohnavur from October 2019 to March 2020. Sociodemographic profile and diabetic characteristics of the study group were obtained and analysed. Diagnosis of Diabetic Neuropathy was done by using the diagnostic method proposed by American Diabetic Association.

Results: Of the total study population with mean age 59.43 years, 63% had family history of diabetes. Almost 70% had poor diabetic control. Statistically significant relationships were found between neuropathy and duration of diabetes, glycaemic control, history of hypertension, monofilament test and pinprick sensation.

Conclusions: In this study, glycemic control, dyslipidemia and hypertension were modifiable risk factors for diabetic neuropathy. Early interventional programs to sensitize diabetics on these factors could improve the quality of life of Diabetic patients.

 


Keywords


Case control study, Diabetic peripheral neuropathy, Glycaemic control, Risk factors

Full Text:

PDF

References


Brinati LM, Diogo NAS, Moreira G. Prevalence and factors associated with peripheral neuropathy in individuals with diabetes mellitus. Revista De Pesquisa: Cuidado Fundamental Online. 2017;9(2),347-55.

Rubino A, Rousculp MD, Davis K, Wang J, Bastyr EJ, Tesfaye S. Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom. Prim Care Diabetes. 2007;1:129-34.

O’brien PD, Sakowski SA, Feldman EL. Mouse models of diabetic neuropathy. Ilar J. 2014;54:259-72.

Wu EQ, Borton J, Said G, Le TK, Monz B, Rosilio M, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin. 2007;23:2035-42.

Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. The Lancet Neurology. 2012;11(6):521-34.

Won JC, Park TS. Recent advances in diagnostic strategies for diabetic peripheral neuropathy. Endocrinol Metab. 2016;31(2):230-8.

Ning G. Progress in the diagnosis of diabetic peripheral neuropathy. Chinese J Practical Int Med. 2007;7:487-9.

Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 2nd Edition, Oxford University Press. 1996.

Kalra P, Kachhwaha CP, Singh HV. Prevalence of gestational diabetes mellitus and its outcome in western Rajasthan. Indian J Endo. 2013;17(4):677-80 .

Smieja M, Hunt DL, Edelman D, Etchells E, Cornuz J, Simel DL. Clinical examination for the detection of protective sensation in the feet of diabetic patients. J General Internal Med. 1999;14(7):418-24.

Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136-54.

Cristian A, Remus A. Diabetic neuropathy prevalence and its associated risk factors in two representative groups of Type 1 and Type 2 diabetes mellitus patients from Bihor County. Indian J Endo. 2008;17:77-80 .

Barbosa AP, Medina JL, Ramos EP, Barros HP. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab. 2001;27:496-502.

Gill HK, Yadav SB, Ramesh V, Bhatia E. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med. 2014;60:270-5.

Ziegler D, Landgraf R, Lobmann R, Reiners K, Rett K, Schnell O, et al. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Diabetes Res Clin Pract. 2001;139:147-54.

Olesen KF, Reynheim AL, Joensen L, Ridderstråle M, Kayser L, Maindal HT, et al. Higher health literacy is associated with better glycemic control in adults with type 1 diabetes: a cohort study among 1399 Danes. BMJ Open Diabetes Res Care. 2017;5(1):e000437.

Gedik S, Kocoglu D. Self-efficacy level among patients with type 2 diabetes living in rural areas. Rural Remote Health. 2018;18(1):4262.

Babazadeh T, Dianatinasab M, Daemi A, Nikbakht HA, Moradi F, Ghaffari F. Association of self-care behaviors and quality of life among patients with type 2 diabetes mellitus: Chaldoran County, Iran. Diabetes Metab J. 2017;41(6):449-56.

Christiansen JS. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care. 1978;1:146-9.

Levy LA. Smoking and peripheral vascular disease. Podiatric medical update. Clin Podiatr Med Surg. 1992;9:165-71.

Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care. 1990;13:434-7.

Mørkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: a study of type 2 diabetic outpatients in Bangladesh. Int J Diab Developing Countries. 2010;30(1):11.

Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MR, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Synd. 2012;4(1):21.

Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Tirgoviste C. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the Eurodiab IDDM Complications Study. Diabetologia. 1996;39(11):1377-84.

Pawde PP, Thampi RR. Prevalence and risk factors of diabetic peripheral neuropathy among type-2 diabetic patients presenting to SMIMS hospital, Kulasekharam, Kanyakumari district, Tamil Nadu, India. Int J Med Sci Public Health. 2013;2(1):73-6.

Hafshejani MA, Majdzadeh R, Mansournia N, Mansournia MA. Risk factors of peripheral neuropathy in patients with type 2 diabetes in Isfahan: results of a cohort study in Iran. Biomed Res Ther. 2018;5(12):2926-36.

Marvasti SK, Abolghasemi J, Heydari I, Rimaz SH. Effective Factors in the time of development of neuropathy in type ii diabetic patients. Iranian J Epidemiol. 2017;13:80-9.

Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL. Mortality and other important diabetes related outcomes with insulin vs. other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. 2013;98:668-77.

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.

Gill HK, Yadav SB, Ramesh V, Bhatia E. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med. 2014;60:270-5.

Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Therap. 2008;120(1):1-34.